Autoantibodies against PFDN2 are associated with an increased risk of type 2 diabetes: A case-control study.
Douglas C ChangPaolo PiaggiRobert L HansonWilliam C KnowlerClifton BogardusJonathan KrakoffPublished in: Diabetes/metabolism research and reviews (2017)
Anti-PFDN2 antibodies are associated with T2DM and might be a useful biomarker. These findings indicate that autoimmunity may play a role in T2DM in Southwest American Indians, especially among adults presenting with young onset of disease.